Table 3 Prevalence of HPV and EBV in different histopathological grades and TN classification
HPV+ n = 45 | HPV- n = 109 | EBV+ n = 42 | EBV- n = 112 | p value | |
|---|---|---|---|---|---|
G1 | 7 (15.6) | 7 (6.4) | 4 (9.5) | 10 (8.9) | >0.05 |
n = 14 | |||||
G2 | 37 (82.2) | 89 (81.7) | 34 (81.0) | 92 (82.2) | |
n = 126 | |||||
G3 | 1 (2.2) | 13 (11.9) | 4 (9.5) | 10 (8.9) | |
n = 14 | |||||
P | <0.05* | >0.05 | |||
T1 | 0 | 0 | 0 | 0 | >0.05 |
n = 0 | |||||
T2 | 7 (15.6) | 26 (23.8) | 6 (14.3) | 27 (24.1) | |
n = 33 | |||||
T3 | 9 (20.0) | 22 (20.2) | 8 (19.0) | 24 (21.4) | |
n = 31 | |||||
T4 | 29 (64.4) | 60 (55.0) | 28 (66.7) | 61 (54.5) | |
n = 89 | |||||
p | >0.05 | >0.05 | |||
No | 6 (13.3) | 24 (22.0) | 26 (61.9) | 4 (3.6) | >0.05 |
n = 30 | |||||
N1 | 6 (13.3) | 26 (23.9) | 7 (16.7) | 25 (22.3) | |
n = 32 | |||||
N2 | 25 (55.6) | 52 (47.7) | 7 (16.7) | 70 (62.5) | |
n = 77 | |||||
N3 | 8 (17.8) | 7 (6.4) | 2 (4.7) | 13 (11.6) | |
n = 15 | |||||
p | >0.05 | >0.05 | |||